What Does It Feel Like to Control a Robot With Your Mind?
Scott Imbrie's 1985 car accident left him with a broken neck and paralyzed limbs, but four decades later, he achieved something that sounded impossible: shaking hands with a robotic arm that felt like his own body. Through an experimental brain-computer interface featuring implanted electrode arrays, Imbrie has become one of the first humans to experience bidirectional neural control—not just commanding robotic limbs with his thoughts, but receiving tactile sensations back through the same implant.
"I still get goosebumps when I think about that initial contact," Imbrie told IEEE Spectrum, describing the moment he first felt artificial touch through his neural implant. The sensation represents a milestone in bidirectional BCI development, where patients can both send motor commands and receive sensory feedback through the same neural pathway.
Imbrie's four-decade journey from accident to experimental subject illustrates both the promise and the patience required for advanced BCI development. His experience offers rare insights into what long-term neural implant recipients actually feel during daily use—from the initial adaptation period to the psychological impact of controlling external devices through direct neural signals.
The Technical Foundation Behind Tactile Feedback
Imbrie's implant system uses intracortical electrode arrays placed in both motor and sensory regions of his cortex. Unlike traditional motor-only BCIs that decode movement intentions, his system employs electrical stimulation to create artificial touch sensations—a technique called intracortical microstimulation (ICMS).
The bidirectional approach requires precise electrode placement in both the primary motor cortex (M1) for movement decoding and the primary somatosensory cortex (S1) for tactile feedback. When Imbrie attempts to move his paralyzed hand, the motor cortex electrodes capture neural firing patterns and translate them into robotic arm commands. Simultaneously, pressure sensors on the robotic hand trigger electrical pulses through the somatosensory electrodes, creating the perception of touch.
This dual-direction neural communication represents a significant advance over current commercially available systems, which focus exclusively on motor output. The technical challenge lies in delivering stimulation parameters that create natural-feeling sensations without causing tissue damage or unwanted side effects.
Living With Experimental Neural Technology
Imbrie's daily experience with the BCI system reveals both capabilities and limitations that rarely appear in research publications. The initial learning curve required weeks of training sessions where his brain adapted to interpret the artificial electrical stimulation as genuine touch sensations. Early sessions produced tingling or buzzing sensations, but over time, these evolved into more natural-feeling pressure and texture perception.
The psychological impact proved as significant as the technical achievement. "There's something profound about feeling an artificial limb as part of your body," Imbrie explained. This phenomenon, known as embodiment, occurs when the brain integrates the robotic prosthetic into its body schema—essentially treating the artificial limb as a natural extension.
However, the system requires constant calibration and maintenance. Neural signals can drift over time due to tissue responses around the electrodes, requiring regular recalibration sessions. The current setup also limits Imbrie's mobility, as the system connects to external computers and power sources.
Implications for BCI Clinical Translation
Imbrie's experience highlights critical factors for the broader BCI industry's path toward clinical adoption. His decades-long journey from injury to experimental subject underscores the extended development timeline required for sophisticated neural interfaces. Current industry leaders like Neuralink Corp and Synchron are pursuing similar bidirectional capabilities, though most current trials focus on motor output alone.
The integration of somatosensory feedback represents a crucial step toward practical neuroprosthetics. Without tactile sensation, users must rely on visual feedback alone, limiting the speed and naturalness of prosthetic control. Companies developing advanced robotic prosthetics—including those tracked by humanoidintel.ai for humanoid robotics applications—increasingly recognize that neural feedback loops will be essential for natural human-robot interaction.
Imbrie's long-term experience also provides valuable data on biocompatibility and device longevity—critical factors for FDA approval of chronic neural implants. His stable neural interface performance over extended periods supports the feasibility of permanent implanted systems.
The Road to Widespread Adoption
Current barriers to broader adoption include surgical complexity, system costs, and the need for specialized technical support. Imbrie's system requires a team of engineers and researchers for maintenance and optimization—resources unavailable in typical clinical settings.
The industry is working toward more autonomous systems that require minimal technical oversight. Companies like Precision Neuroscience are developing thinner, more flexible electrode arrays designed for easier implantation and reduced tissue response. Meanwhile, Blackrock Neurotech continues advancing the Utah array technology that forms the foundation for many current bidirectional BCI systems.
For patients awaiting these technologies, Imbrie's experience offers both hope and realistic expectations. The technology works, but implementation remains complex and experimental. His journey from experimental subject to advocate illustrates how early adopters play crucial roles in advancing the field toward eventual clinical availability.
Key Takeaways
- Scott Imbrie achieved bidirectional BCI control 40 years after his spinal cord injury, demonstrating long-term feasibility of neural interfaces
- Somatosensory feedback through ICMS creates natural-feeling touch sensations when controlling robotic prosthetics
- The embodiment effect allows users to perceive artificial limbs as extensions of their own bodies
- Current systems require extensive technical support and regular calibration, limiting clinical scalability
- Long-term implant stability supports the development pathway for commercial bidirectional BCI systems
Frequently Asked Questions
How long did it take Scott Imbrie to learn to use his brain implant effectively?
Imbrie's adaptation occurred over several weeks of training sessions. Initial electrical stimulation felt like tingling or buzzing, but his brain gradually learned to interpret these signals as natural touch sensations. The motor control learning curve was similar, requiring practice sessions to achieve fluid robotic arm movement.
What does tactile feedback through a brain implant actually feel like?
According to Imbrie, the sensations evolved from artificial tingling to natural-feeling pressure and texture perception. The electrical stimulation through somatosensory cortex electrodes creates touch sensations that the brain interprets as coming from the robotic hand, not from the implant site.
Are bidirectional BCIs available for clinical use outside of research studies?
No bidirectional BCI systems are currently approved for commercial use. All existing bidirectional capabilities remain in experimental research phases. Most FDA-approved neural devices focus on either motor output or sensory stimulation, but not both simultaneously through the same interface.
How reliable are current brain-computer interfaces for daily use?
Imbrie's system requires regular calibration and technical maintenance, limiting independence. Neural signal quality can change over time due to tissue responses around electrodes, requiring ongoing optimization. Current systems are not yet ready for unsupervised home use.
What safety considerations exist for long-term brain implants like Imbrie's?
Long-term neural implants must address infection risk, tissue scarring around electrodes, and potential device failure. Imbrie's extended experience provides valuable safety data, but each patient's response varies. Ongoing monitoring for complications remains essential for experimental participants.